Business Wire
Motus GI to Present at Biotech Showcase™ 2019
Tuesday, 01 January 2019 21:06
– Presentation with live audio webcast Tuesday, January 8, 2019 at 4:00 PM PST –
Read more...
 
Harpoon Therapeutics Announces Preliminary Safety and Pharmacology Data from its HPN424 Phase 1 Trial in Prostate Cancer
Tuesday, 01 January 2019 21:06
HPN424 dose escalation proceeding to identify Phase 2 therapeutic dose
Read more...
 
Harpoon Therapeutics Announces Preliminary Safety and Pharmacology Data from its HPN424 Phase 1 Trial in Prostate Cancer
Tuesday, 01 January 2019 21:06
HPN424 dose escalation proceeding to identify Phase 2 therapeutic dose
Read more...
 
Myonexus Therapeutics Receives Orphan Drug Designation for MYO-102, an Investigational Gene Therapy for Alpha-sarcoglycanopathy (LGMD2D)
Tuesday, 01 January 2019 21:06
Media Contact for Nationwide Children’s Hospital:Gina Bericchia614-355-0495 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Myonexus Therapeutics Receives Orphan Drug Designation for MYO-102, an Investigational Gene Therapy for Alpha-sarcoglycanopathy (LGMD2D)
Tuesday, 01 January 2019 21:06
Media Contact for Nationwide Children’s Hospital:Gina Bericchia614-355-0495 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Global Prader-Willi Syndrome Therapeutics Market 2018-2022 | Designations for Special Drugs Impacting Market Growth | Technavio
Tuesday, 01 January 2019 21:06
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200www.technavio.com
Read more...
 
Global Prader-Willi Syndrome Therapeutics Market 2018-2022 | Designations for Special Drugs Impacting Market Growth | Technavio
Tuesday, 01 January 2019 21:06
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200www.technavio.com
Read more...
 
AVEO Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
Tuesday, 01 January 2019 21:06
AVEO Contact:David Pitts, Argot Partners(212) 600-1902 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
AVEO Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference
Tuesday, 01 January 2019 21:06
AVEO Contact:David Pitts, Argot Partners(212) 600-1902 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
PathMaker Neurosystems Appoints Medical Device Industry Veteran Jean-Luc Boulnois to Board of Directors
Tuesday, 01 January 2019 21:06
Read more...
 
<< Start < Prev 61 62 63 64 65 66 67 68 Next > End >>

Page 65 of 68

Newsletter